Lopez-Beltran A.; Henriques V.; Cimadamore A.; Santoni M.; Cheng L.; Gevaert T.; Blanca A.; Massari F.; Scarpelli M.; Montironi R., The identification of immunological biomarkers in kidney cancers, «FRONTIERS IN ONCOLOGY», 2018, 8, Article number: 456 , pp. 1 - 13 [Scientific article]Open Access
Iacovelli R.; Cossu Rocca M.; Galli L.; Sabbatini R.; De Giorgi U.; Santini D.; Facchini G.; Mosca A.; Atzori F.; Zucali P.; Fornarini G.; Massari F.; Buti S.; Ricotta R.; Masini C.; Toscani I.; Biasco E.; Guida A.; Lolli C.; De Lisi D.; Rossetti S.; Terrone C.; Scartozzi M.; Miggiano C.; Pastorino A.; Bersanelli M.; Carlo-Stella G.; Pinto C.; Nobili E.; Nole F.; Tortora G.; Porta C., The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma, «ANTI-CANCER DRUGS», 2018, 29, pp. 705 - 709 [Scientific article]
Santoni M.; Massari F.; Piva F.; Carrozza F.; Di Nunno V.; Cimadamore A.; Martignetti A.; Montironi R.; Battelli N., Tivozanib for the treatment of renal cell carcinoma, «EXPERT OPINION ON PHARMACOTHERAPY», 2018, 19, pp. 1021 - 1025 [Scientific article]
Cimadamore A.; Scarpelli M.; Piva F.; Massari F.; Gasparrini S.; Doria A.; Cheng L.; Lopez-Beltran A.; Montironi R., Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets, «FUTURE ONCOLOGY», 2017, 13, pp. 1105 - 1114 [Scientific article]
Ciccarese C.; Iacovelli R.; Brunelli M.; Massari F.; Bimbatti D.; Fantinel E.; De Marco V.; Porcaro A.B.; Martignoni G.; Artibani W.; Tortora G., Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies, «EUROPEAN JOURNAL OF CANCER», 2017, 83, pp. 237 - 246 [Scientific article]
Massari F.; Di Nunno V.; Ciccarese C.; Graham J.; Porta C.; Comito F.; Cubelli M.; Iacovelli R.; Heng D.Y.C., Adjuvant therapy in renal cell carcinoma, «CANCER TREATMENT REVIEWS», 2017, 60, pp. 152 - 157 [Scientific article]
Munari E.; Cima L.; Massari F.; Bertoldo F.; Porcaro A.B.; Calio A.; Riva G.; Ciocchetta E.; Ciccarese C.; Modena A.; Iacovelli R.; Sava T.; Eccher A.; Ghimenton C.; Tortora G.; Artibani W.; Novella G.; Bogina G.; Zamboni G.; Sanguedolce F.; D'Amuri A.; Martignoni G.; Brunelli M., Cathepsin K expression in castration-resistant prostate carcinoma: A therapeutical target for patients at risk for bone metastases, «THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS», 2017, 32, pp. 243 - 247 [Scientific article]
Ciccarese, Chiara; Montironi, Rodolfo; Fiorentino, Michelangelo; Martignoni, Guido; Brunelli, Matteo; Iacovelli, Roberto; Lopez-Beltran, Antonio; Cheng, Liang; Scarpelli, Marina; Moch, Holger; Tortora, Giampaolo; Massari, Francesco, Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?, «CURRENT DRUG METABOLISM», 2017, 18, pp. 0 - 0 [Scientific article]
Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo, Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer, «UROLOGIC ONCOLOGY», 2017, 35, pp. 541 - 541.e13 [Scientific article]
Cimadamore A.; Gasparrini S.; Scarpelli M.; Doria A.; Mazzucchelli R.; Massari F.; Cheng L.; Lopez-Beltran A.; Montironi R., Epigenetic modifications and modulators in prostate cancer, «CRITICAL REVIEWS IN ONCOGENESIS», 2017, 22, pp. 439 - 450 [Scientific article]
Ciccarese C.; Di Nunno V.; Iacovelli R.; Massari F., Future perspectives for personalized immunotherapy in renal cell carcinoma, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2017, 17, pp. 1049 - 1052 [Scientific article]
Bianconi M.; Faloppi L.; Lopez-Beltran A.; Cheng L.; Cimadamore A.; Gasparrini S.; Massari F.; Scarpelli M.; Montironi R., Immunotherapy in genitourinary cancers: Where are we going?, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2017, 2, pp. 73 - 78 [Scientific article]
Ciccarese C.; Montironi R.; Iacovelli R.; Massari F., Localized prostate cancer genotyping: Another step towards personalized therapy, «TRANSLATIONAL CANCER RESEARCH», 2017, 6, pp. 246 - 248 [Scientific article]Open Access
Conteduca V.; Caffo O.; Lolli C.; Aieta M.; Scarpi E.; Bianchi E.; Maines F.; Schepisi G.; Salvi S.; Massari F.; Carrozza F.; Veccia A.; Chiuri V.E.; Campadelli E.; Facchini G.; De Giorgi U., Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone, «THE PROSTATE», 2017, 77, pp. 1012 - 1019 [Scientific article]
Blanca, Ana; Cheng, Liang; Montironi, Rodolfo; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo; Raspollini, Maria Rosaria; Scarpelli, Marina; Lopez-Beltran, Antonio, Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice, «CURRENT DRUG METABOLISM», 2017, 18, pp. 0 - 0 [Scientific article]
